04/18/2023 Grunenthal GmbH (GRUPHA) EUR300m 144A/Reg S sr sec 1st lien notes due 05/15/30 (7y). NC3 (MWC B+50bp), then at 103.375, 101.688, 100. Equity claw: 3y 40% at 106.75. B1/BB-/BB+ (positive/stable/stable). Via DB (B&D)/GS/ING/RBC/UniCredit jt glocos/Commerz/BNP jt bks. No reg rights. List ISE. NY law. Settles 04/25 (T+5). Reg S ISIN: XS2615562274. Px talk: 6.75%-7.00%. Priced: 6.75% at 100. +432bp vs DBR 0% 02/15/30. Roadshow 04/17-18 (investor call at 11am UKT 04/18). Books closed at 2:30pm UKT 04/18. UOP: refinance the EUR200m Neon bridge loan facility incurred to fund the EUR494m acquisition of Nebido from Bayer AG on 11/22/22, repay EU75m Schuldschein private placement promissory notes, GCP. Wholly-owned by the Wirtz family. Biz: Leading innovator in pain treatments. HQ: Aachen, Germany.
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.